Key points are not available for this paper at this time.
Dr. Thomas Stossel argues for increasing interaction between academic scientists and the companies that manufacture biomedical treatments.
Share your take
Add a clinician perspective alongside expert commentary.
Thomas P. Stossel (Wed,) studied this question.